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Brain tumours are caused by abnormal and uncontrolled growth of cells inside the brain or spinal canal. They are the second cause of death related 
to Cancer in children and adults younger than 
34 years [1]. The primary tumours are those that 
start in the brain and are categorised in four main 
types: Gliomas, Meningiomas, Pituitary adenomas 
and Nerve sheath tumours. The most popular 
grading system for tumours is that suggested by 
the World Health Organization (WHO). Regarding 
to the WHO grading system, the tumours are 
graded from I to IV, corresponding to least 
advanced to the most advanced diseases, 
respectively.
Utilising computer-aided procedures for 
medical diagnosis and treatment is a growing 
field of research. Among these procedures, 
Medical Image Analysis plays a substantial role, 
especially in cancer management [2]. The image 
processing applications in Cancer management 
include prediction, screening, biopsy guidance for 
detection, staging, prognosis, therapy planning, 
and therapy response [3]. 
Depending on the imaging modality, images 
provide quantification measures alongside the 
visualisation of the target tissue. Characteristics 
obtained from images such as location, size of 
the tumour, and imaging parameters [4] can 
be used for screening tasks in brain cancer. 
Whole-body Magnetic Resonance (MR) imaging 
is another way of screening for Cancer. In this 
method, metastases that are caused by a tumour; 
are monitored in other organs of the body. 
Research shows that MR imaging provides more 
accurate results for detection of metastases in 
comparison to other modalities [5]. 
Using diffusion weighted imaging is popular for 
investigating tumour response and allows early 
predictions of tumour presence [6]. However, 
conventional MR imaging can also be used 
for prediction tasks in brain or other types of 
cancers. Kawahara et al. [7] investigated four 
different factors of T1 protocols and suggested 
that by combining them and using multivariate 
regression analysis is helpful for prediction of 
high-grade meningioma. 
Medical Image Analysis research methods 
commonly consist of several parts, which use 
different algorithms in a sequence or a pipeline. 
Some pre-processing stages maybe used to 
prepare the data for optimum results. These 
algorithms consist of segmentation, feature 
extraction and classification. Segmentation is 
based on visual characteristics of the images, 
which are related to their grey-levels. Features are 
statistical measurements and information that can 
be extracted from a selected part of the image. 
Classification is the process of categorisation the 
data based on their features which is a necessary 
stage for grading the tumours. These methods can 
be implemented independently as the main or as 
an auxiliary stage alongside with the main part of 
the algorithm.
Image processing and pattern recognition 
algorithms are widely used for analysis and 
interpretation of medical images. Feature 
extraction is the most important and impartible 
element of classification and pattern recognition 
tasks. In the case of medical images, such as 
MRI, the reduction of dimensionality is of high 
importance. MRI images are three-dimensional 
volumetric data acquired with different 
protocols, which lead to extraction of high 
dimensional information in the form of statistical 
features. Classification of high dimensional data 
is based on these extracted features.
Georgias et al. [8] utilised a pattern recognition 
system based on support vector machine 
classifiers and combination of features extracted 
form MRI images and spectroscopy ratios. 
Their method efficiently discriminates between 
meningioma and metastatic brain tumours. 
Zacharaki et al. [9] performed a comprehensive 
assessment of pattern recognition methods on 
detection of different types of brain tumours 
and grading gliomas based on WHO grading 
system. They used a set of different image 
features including: intensity, shape, statistical 
characteristics and texture. Regarding to the high 
dimensionality of the feature space, they used 
feature selection methods to find an optimum 
feature subset.
Angelini et al. [10] proposed a differential 
analysis system to measure the growth of 
low-grade glioma in MRI brain images. Joshi 
et al. [11] developed a system for detection of 
Astrocytoma cancer tumours and classify them 
based on artificial neural network. Georgiadis et 
al. [12] proposed a method to classify primary 
and metastatic tumours, which originated outside 
the brain. Soltaninejad et al. [13] proposed a 
framework for classifying different tumour 
grades exploring information from several MRI 
acquisition protocols, see figures 1 and 2 for the 
algorithmic layout and initial results. 
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MRI Brain Tumour Imaging 
and Analysis
MRI is the most commonly used imaging 
modality for brain tumour assessment 
[14], as it provides efficient evaluation of 
tumour analysis and the acquisition is non-
invasive [15]. 
Segmentation in medical images 
means partitioning the pixels to detect 
and separate the target area usually a 
tissue or a lesion from the background 
and healthy tissues. In some research 
fields, segmentation of a specific tissue 
or tumour is the main purpose. In others, 
segmentation is an intermediate stage for 
further analysis such as classification or 
other measurements. For the case of brain 
tumours, it is a difficult task regarding to 
the characteristics of the tumour in the 
MR images [15]. The first stage in most 
medical image processing research is 
pre-processing. The most popular pre-
processing method is noise suppression or 
correcting for non-uniformities. There are 
several algorithms proposed for this task 
that beside their benefits, they may have 
negative effects on further processing 
stage [16]. Before any analysis on a specific 
target in the image, it is necessary to 
segment that from other parts in the 
image. Image segmentation algorithms 
use edge, region or intensity properties of 
the target tissue in the image to separate 
them from the background [17]. The aim 
of edge-based segmentation methods 
is to find the boundary of two adjacent 
regions that have different characteristics. 
One of the most popular algorithms for 
detection of tumour edges in MRI images 
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 Figure 1. The flowchart of proposed method.
Figure 2: Examples of Grade II, III, and IV brain oedemas: a) original MRI slice, b) superpixel segmentation, c) 
manual segmentation.
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is using level-sets [18] and/or combining it 
with classification or clustering methods [19]. 
In our work [13], we use the properties from 
sub-regions of the image. These sub-regions 
are grouped together based on their similar 
characteristics and their spatial adjacency. The 
image is segmented to small partitions using 
a linear iterative clustering superpixel (SLIC) 
algorithm [20]. Superpixels are groups of pixels 
with similar features. 
Feature extraction
Feature extraction is a step used for both 
segmentation and classification of tissues 
in medical images. Since the tumours have 
different types and grades and there are 
different acquisition protocols, the tumour 
region in the image may have different 
properties. So, a wide range of feature types can 
be used in image analysis of brain tumours [15]. 
Intensity features are most popular in this field. 
The idea is that tumours have different intensity 
in comparison to other healthy tissues. Several 
statistical measures can be calculated from 
the pixels of the target area in the image. The 
other common features are based on textural 
patterns [22], as different tumour regions have 
specific textures. Fractal-based features are 
also used for brain tumour segmentation and 
detection [23], as well as context features for 
segmentation in MRI brain images [24].
The features may be extracted from a 
single MRI acquisition protocol [25] (i.e. 
FLAIR, T1-weighted, T2-weighted, etc.) or 
using different protocols together [26]. Even 
combinations of features from different 
modalities are investigated [27]. However, such 
strategy dramatically increases the number of 
features acquired, and to overcome this, the 
employment of feature selection methods 
for choosing an efficient set of them with the 
highest classification accuracy [28] should be 
considered.
Classification for grading
Classification in machine learning means 
finding a model, based in a set of training 
data, in order to categorise a general set of 
data. Classification algorithms can be used in 
supervised segmentation of MRI images [29]. 
Automatic brain tumour segmentation methods 
often use this type of segmentation [30]. Some 
further analysis tasks for medical images are 
also involved with classification. One of them is 
grading the tumours based on their type, which 
is also called tumour grading. The data for 
training the classification model are the features 
that are extracted from the images. Each 
feature vector has a label corresponding to 
the tumour type. The aim of classification is to 
find the class labels (i.e. tumour types) for the 
new images. Several classification methods are 
used for this purpose. A popular classification 
method in many medical applications is 
Support Vector Machine (SVM) that is used for 
brain tumour classification [9]. This method is 
suitable for two classes and can be extended for 
multiclass cases. In [31] a method is suggested 
based on combination of Neural Networks and 
Principal Component Analysis (PCA) for reducing 
the feature space and providing a more robust 
classifier. In [13] we investigated the application 
of a linear support vector machine classifier using 
datasets from different MRI imaging protocols 
in order to differentiate tumour grades II, III and 
IV. The assumption to use several protocols 
rather than a single approach is to obtain more 
information for training the classification system. 
Another issue we investigated is using multiple 
superpixel features from these protocols to 
assess their efficiency for classification. By 
increasing the feature space, it seems that 
advanced classification techniques should be 
utilised to improve the grading task.
Discussion and outlook
Image analysis and computer vision techniques 
are widely used for detection and grading 
the tumours in medical images. Due to 
developments in imaging and processing 
techniques, using the state-of-the-art pattern 
recognition and computer vision in advanced 
imaging modalities with multi-modal approach 
attracts the most attention in today’s research.
The variety of issues and complexity of brain 
in MRI images had made it a challenging task to 
perform automated image analysis. The current 
brain image analysis methods, due to their 
long computational time, are mostly confined 
in research-focused institutions, and are not 
applicable for generic clinical usage. Most of them 
are for specific imaging protocols that target 
specific lesion types, and usually are tested on a 
relative small group of data.  
Any proposed automated MRI brain tumour 
segmentation/grading system should consider 
the real-world issues and be acceptable by the 
physicians for everyday use. Data that is used 
for training such systems should come from 
multi-centre collaborations and try to cover as 
many different imaging protocols, tumour types, 
and grades, as possible. The provided solutions 
besides being efficient in terms of speed, 
accuracy, and robustness, they also should be 
comprehensive and standardised. The challenge 
remains for state-of-the-art computational 
techniques to bridge the gap between research-
oriented implementations and clinical routine 
applications.
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Prognostic Value of Tumour-Infiltrating Lymphocytes 
in Triple-Negative Breast Cancers From Two Phase 
III Randomised Adjuvant Breast Cancer Trials: ECOG 
2197 and ECOG 1199 
Adams S, Gray RJ, Demaria S, et al. Journal of Clinical Oncology 
2014; 20 Sep;32(27):2959-66.
Purpose: Recent studies suggest that tumour-infiltrating lympho-
cytes (TILs) are associated with disease-free (DFS) and overall survival 
(OS) in operable triple-negative breast cancer (TNBC). We sought to 
validate the prognostic impact of TILs in primary TNBCs in 2 adjuvant 
phase III trials conducted by the Eastern Cooperative Oncology Group 
(ECOG). Patients and Methods: Full-face hematoxylin and eosin–
stained sections of 506 tumours from ECOG trials E2197 and E1199 
were measured for density of TILs in intraepithelial (iTILs) and stromal 
compartments (sTILs). Patient cases of TNBC from E2197 and E1199 
were randomly selected, based on availability of sections. For the 
primary end-point of DFS, association with TIL scores was determined 
by fitting proportional hazards models stratified on study. Secondary 
end-points were OS and distant recurrence-free interval (DRFI). Reporting 
recommendations for tumour marker prognostic studies criteria were 
followed and all analyses were prespecified. Results: The majority 
of the 481 cancers assessed had TILs (sTILs, 80%; iTILs, 15%). With a 
median follow-up of 10.6 years, higher sTIL scores correlated with better 
prognosis; for every 10% increase in sTILs, a 14% reduction of risk of 
recurrence or death (P=0.02), an 18% reduction of risk of distant recur-
rence (P=0.04), and a 19% reduction of risk of death (P=0.01) were 
estimated. Multivariable analysis confirmed sTILs are an independent 
prognostic marker of DFS, DRFI and OS. Conclusions: In two national 
randomised clinical trials using contemporary adjuvant chemotherapy, 
we have confirmed that stromal lymphocytic infiltration constitutes 
a robust prognostic factor in TNBCs. Studies assessing outcomes and 
therapeutic efficacies should consider stratification for this parameter.    
Reviewer’s opinion: This study addressed the contribution of the 
immune system to outcome in the least favourable subtype of early 
stage breast cancer:- a highly topical issue, particularly in view of the 
emerging efficacy of immune-based therapeutics in many cancers, 
including PD-1/2 and PD1-2 ligand targeting, Sipuleucel-T (prostate 
cancer) and ipilimumab (melanoma). Previous studies suggested the 
predictive and prognostic impact of tumour-infiltrating-lymphocyte 
(TIL) density in breast cancer in neo-adjuvant and adjuvant settings. 
The strength of this study is the inclusion of a large number of patients 
(n=481), a subset with assessable tumour were representative of larger 
trial population, use of a previously validated simple and reproducible 
assessment of TIL density with good concordance between two blinded 
pathologists, and long-term (>10 years) thorough clinical follow-up.  
The key finding was that stromal TIL density positively correlated 
with disease-free survival, distant recurrence-free interval and overall 
survival in both uni- and multi-variate analyses (not including tumour 
grade). It is notable that the density of intra-epithelial TILs (i.e. those in 
direct contact with tumour cell islets) was not correlated with clinical 
outcomes, and was generally low. Therefore further characterisation 
of the phenotype and function of the stromal TILs is important.  It 
is unexpected that so simple a measure of immune infiltration (CD3 
T-cell density) correlates well with outcome, given the diversity of 
leucocytes present in tumours. Future challenges will be to standardise 
and possibly automate assessment of TIL density in routine diag-
nostic histopathology laboratories, and to determine how to combine 
conventional cytotoxic chemotherapy, targeted therapies directed 
against defective DNA damage repair (i.e PARP inhibitors) and nascent 
immunotherapies in this difficult-to-treat and undoubtedly immuno-
genic cancer. It remains unclear how an estimate of TIL density on a 
pathology report would change clinical decision-making, although 
patients with no TIL infiltrate might be considered for trials involving 
immune-stimulating treatments. – AR
